Scientists finally explain why chronic constipation treatments often fail
Nagoya University researchers found a mucin-degrading bacterial duo that strips the colon’s protective mucus, leaving stool dry and hard and explaining why standard laxatives often fail; higher levels were observed in Parkinson’s patients and blocking the bacteria’s mucus-degrading enzyme prevented constipation in mice, pointing to a microbiome-targeted therapeutic approach.
Why it mattersMucin-degrading bacterial duo presence warrants prioritizing microbiome-targeted enzyme inhibitors for constipation therapies.